Mechanism of SOS1-IT1 promoting EZH2 expression in human endometrial cancer cells by regulating acetylation modification

LIU Hong-yang LOU Xue-ling ZHANG Rong-jing FENG Quan-ling GUO Kai-ge WANG Hao-fan LI Ying-ying WAN Jun-hu ZHANG Lin-dong

Acta Anatomica Sinica ›› 2025, Vol. 56 ›› Issue (4) : 444-451.

PDF(2274 KB)
Welcome to visit Acta Anatomica Sinica! Today is Chinese
PDF(2274 KB)
Acta Anatomica Sinica ›› 2025, Vol. 56 ›› Issue (4) : 444-451. DOI: 10.16098/j.issn.0529-1356.2025.04.009
Cancer Biology

Mechanism of SOS1-IT1 promoting EZH2 expression in human endometrial cancer cells by regulating acetylation modification

  • LIU  Hong-yang1  LOU  Xue-ling1  ZHANG Rong-jing1  FENG  Quan-ling1  GUO  Kai-ge1  WANG  Hao-fan1  LI  Ying-ying1  WAN  Jun-hu2*  ZHANG  Lin-dong1*
Author information +
History +

Abstract

Objective To explore the molecular mechanism by which SOS Ras/Rac guanine nucleotide exchange factor 1-intronic transcript 1 (SOS1-IT1) affects enhancer of zeste homolog 2 (EZH2) protein expression in endometrial cancer cells Ishikawa and RL95-2.   Methods  Lentiviral transfection of short hairpin RNA(shRNA) and overexpression plasmid were used in Ishikawa and RL95-2 cell lines to knock down and overexpress SOS1-IT1. The mechanism of EZH2 expression regulation was studied using Real-time PCR, Western blotting, and chromatin immunoprecipitation.  Results The expression of SOS1-IT1 and EZH2 genes was positively correlated in endometrial cancer tissues. Knocking down SOS1-IT1 significantly reduces the expression of EZH2, inhibited the proliferation and migration of Ishikawa and RL95-2 cells, and could reduced the acetylation of histone H3 at position 27 (H3K27) and the enrichment of CREB binding protein (CBP) in the EZH2 gene promoter region. Overexpression of SOS1-IT1 could increased the expression of EZH2 and enhance the acetylation of H3K27 and the enrichment of CBP. CBP could bind to SOS1-IT1 RNA, and this binding ability was weakened when CBP was knocked down. Conclusion   SOS1-IT1 can promote the expression level of EZH2 in endometrial cancer cells Ishikawa and RL95-2 by regulating the acetylation modification level of the EZH2 gene promoter region, thereby affecting the proliferation and migration ability of endometrial cancer cells. 

Key words

Endometrial cancer / Long non-coding RNA / SOS Ras/Rac guanine nucleotide exchange factor 1-intronic transcript 1 / Enhancer of zeste homolog 2 / Western blotting / Human

Cite this article

Download Citations
LIU Hong-yang LOU Xue-ling ZHANG Rong-jing FENG Quan-ling GUO Kai-ge WANG Hao-fan LI Ying-ying WAN Jun-hu ZHANG Lin-dong. Mechanism of SOS1-IT1 promoting EZH2 expression in human endometrial cancer cells by regulating acetylation modification[J]. Acta Anatomica Sinica. 2025, 56(4): 444-451 https://doi.org/10.16098/j.issn.0529-1356.2025.04.009

References

[1]Wang Z, Zhang J, Liu Y, et al. An integrated autophagy-related long noncoding rna signature as a prognostic biomarker for human endometrial cancer: a bioinformatics-based approach [J]. Biomed Res Int, 2020, 2020(12): 5717498.
[2]Liu H, Wan J, Feng Q, et al. Long non-coding RNA SOS1-IT1 promotes endometrial cancer progression by regulating hypoxia signaling pathway [J]. J Cell Commun Signal, 2022, 16(2): 253-270.
[3]Roh JW, Choi JE, Han HD, et al. Clinical and biological significance of EZH2 expression in endometrial cancer [J]. Cancer Biol Ther, 2020, 21(2): 147-156.
[4]Fang X, Ni N, Wang X, et al. EZH2 and endometrial cancer development: insights from a mouse model [J]. Cells, 2022, 11(5): 909.
[5]Audia JE, Campbell RM. Histone modifications and cancer[J]. Cold Spring Harb Perspect Biol, 2016, 8(4): a019521.
[6]Chen Q, Yang B, Liu X, et al. Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents [J]. Theranostics, 2022, 12(11): 4935-4948.
[7]McDonald M, Bender D. Endometrial cancer: obesity, genetics, and targeted agents [J]. Obstet Gynecol Clin North Am, 2019, 46(1): 89-105.
[8]Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020 [J]. CA Cancer J Clin, 2020, 70(1): 7-30.
[9]Mitric C, Bernardini MQ. Endometrial cancer: transitioning from histology to genomics[J]. Curr Oncol, 2022, 29(2): 741-757.
[10]Karpel HC, Slomovitz B, Coleman RL, et al. Treatment options for molecular subtypes of endometrial cancer in 2023 [J]. Curr Oncol, 2023, 35(3): 270-278.
[11]Fan J, Wu D, Guo Y, et al. SOS1-IT1 silencing alleviates MPP(+)-induced neuronal cell injury through regulating the miR-124-3p/PTEN/AKT/mTOR pathway [J]. J Clin Neurosci, 2022, 99(5): 137-146.
[12]Fu NN, Liu X, Liu T. Regulation of hepatocellular carcinoma cells by intronic long non coding RNA SOS1-IT1 [J]. Journal of Practical Medicine, 2021, 37(19): 2447-2452,2457. (in Chinese)
付楠楠, 刘蕊, 刘涛. 内含子源性长链非编码RNA SOS1?IT1对肝癌细胞的调控[J]. 实用医学杂志, 2021, 37(19): 2447-2452,2457.
[13]Lu HX, Wei DM, Feng ZhB. Expression and clinical significance of EZH2 in hepatocellular carcinoma[J]. Acta Anatomica Sinica, 2011, 42(1): 75-79. (in Chinese)
陆海霞,危丹明,冯震博. EZH2在肝细胞癌中的表达及临床意义[J],解剖学报, 2011, 42(1): 75-79.
[14]Chen L, Zheng X, Liu W, et al. Compound AC1Q3QWB upregulates CDKN1A and SOX17 by interrupting the HOTAIR-EZH2 interaction and enhances the efficacy of tazemetostat in endometrial cancer [J]. Cancer Lett, 2023, 578(12): 216445.

PDF(2274 KB)

Accesses

Citation

Detail

Sections
Recommended

/